Osteocalcin and sclerostin: Background characters or main actors in cardiovascular disease?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Osteocalcin and sclerostin: Background characters or main actors in cardiovascular disease?
Authors
Keywords
-
Journal
DIABETES-METABOLISM RESEARCH AND REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-11
DOI
10.1002/dmrr.3217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obesity and its cardiovascular effects
- (2019) Christian Ortega‐Loubon et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Risk factors and predictive biomarkers of early cardiovascular disease in obese youth
- (2019) Howard Chong Huat Ho et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults
- (2018) Nicola Napoli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
- (2018) E Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis
- (2018) Silvia Pieralice et al. Current Diabetes Reports
- Sclerostin is expressed in the atherosclerotic plaques of patients who underwent carotid endarterectomy
- (2018) Gaetano Leto et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Potential Role for Osteocalcin in the Development of Atherosclerosis and Blood Vessel Disease
- (2018) Alexander Tacey et al. Nutrients
- Vitamin K and osteoporosis: Myth or reality?
- (2017) Andrea Palermo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin
- (2017) I. Levinger et al. OSTEOPOROSIS INTERNATIONAL
- Osteocalcin, Vascular Calcification, and Atherosclerosis: A Systematic Review and Meta-analysis
- (2017) Sophie A. Millar et al. Frontiers in Endocrinology
- Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis
- (2016) Mehmet Kanbay et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- From skeletal to cardiovascular disease in 12 steps—the evolution of sclerostin as a major player in CKD-MBD
- (2015) Vincent M. Brandenburg et al. PEDIATRIC NEPHROLOGY
- Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes
- (2014) Ernesto Maddaloni et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
- (2013) S. Morales-Santana et al. DIABETES CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now